On October 16, 2026 Starton Therapeutics Inc. ("Starton"), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, reported that Chief Medical Officer Dr. Jamie Oliver, Pharm.D., will participate as a panelist at BioFuture 2026, taking place Oct. 27-28, 2026, in New York.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Oliver will join fellow industry leaders to discuss the technologies shaping what comes next across the life sciences, including oncology, CNS, metabolic disease and diagnostics. Details for the event are as follows:
BioFuture 2026
Location: Cure, 345 Park Avenue South, 12th Floor, New York, NY
Session: Spotlight Panel 1A
Panel Title: BioFuture Now: Breakthroughs Shaping the Next Era of Biopharma Trailblazers
Date: Tuesday, Oct. 27, 2026
Time: 10:00-10:55 a.m. ET
To learn more about the event, please visit www.biofuture.com/.
(Press release, Starton Therapeutics, OCT 16, 2026, View Source [SID1234673530])